Cardinal, GE Ask Judge To Toss Imaging Drug Antitrust Suit
By Ben James (June 25, 2012, 8:54 PM EDT) -- Cardinal Health Inc. and GE Healthcare Inc. said Friday that a California federal court should toss a putative antitrust class action over the cardiac imaging agent market, arguing that their distribution deal targeted by the suit was neither illegal nor anti-competitive.
GE Healthcare and Cardinal, which filed separate motions to dismiss radiopharmacy owner PharmaRx Pharmaceutical Inc.'s lawsuit, also own radiopharmacies, which distribute nuclear drugs used to image the heart, like GE Healthcare's Myoview.
PharmaRx's May 31 amended complaint said the defendants denied competitors effective market access when they struck a 2008 deal which under which they refused to sell GE's Myoview...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!